The pre-seed investment was led by QVentures with support from strategic angel investors.
"This seed round gives us an important springboard to further enhance our software and to expand our distribution network of accountancy partners. Having QVentures as our lead investor in this round is a privilege, their excellent portfolio of companies speaks for itself, and we’re delighted they chose to add Meysey to the cohort."
DSW Ventures and XTX Ventures backed the pre-seed round, which will fund prototype optimisation and technical validation.
"InvenireX has developed an exciting platform technology with promising data and early customer traction. This round will help get the technology into the hands of users who can further validate it and drive the company forward into full commercialisation. It’s been a pleasure to work with the InvenireX team who are incredibly talented, dynamic and open to collaboration."
The medtech firm has raised £2.1m from investors including id4 ventures and Brandenburg Kapital to support its ultrasound software.
"We are thrilled to announce this significant funding milestone and the achievement of key regulatory milestones for our ThinkSono Guidance system. This funding will enable us to further advance our mission of revolutionizing medical imaging technology while our partnerships with NYU Langone Health and Temple Health underscore our commitment to delivering innovative solutions that ultimately improve patient outcomes."